PlainRecalls
FDA Drug Low Class III Terminated

Children's Cetirizine Hydrochloride Chewable Tablets, 5 mg, 30-count bottle, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol - 389 350, Gujarat, India; Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 47335-343-83.

Reported: May 31, 2017 Initiated: April 18, 2017 #D-0857-2017

Product Description

Children's Cetirizine Hydrochloride Chewable Tablets, 5 mg, 30-count bottle, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol - 389 350, Gujarat, India; Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 47335-343-83.

Reason for Recall

Failed Tablet/Capsule Specifications: out of specification results for increased tablet hardness.

Details

Units Affected
13,200 bottles
Distribution
Nationwide in the USA and Puerto Rico
Location
Cranbury, NJ

Frequently Asked Questions

What product was recalled?
Children's Cetirizine Hydrochloride Chewable Tablets, 5 mg, 30-count bottle, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol - 389 350, Gujarat, India; Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 47335-343-83.. Recalled by Sun Pharmaceutical Industries, Inc.. Units affected: 13,200 bottles.
Why was this product recalled?
Failed Tablet/Capsule Specifications: out of specification results for increased tablet hardness.
Which agency issued this recall?
This recall was issued by the FDA Drug on May 31, 2017. Severity: Low. Recall number: D-0857-2017.